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Abstract The mammalian DYRK (dual specificity tyrosine
phosphorylated and regulated kinase) family of protein kinases
comprises a number of related, but poorly understood enzymes.
DYRK1A is nuclear while DYRKs 2 and 3 are cytoplasmic. We
recently showed that DYRK2 phosphorylates the translation
initiation factor eIF2B at Ser539 in its O-subunit and thereby
‘primes’ its phosphorylation by glycogen synthase kinase-3. Here
we have used peptides based on the sequence around Ser539 to
help define the specificity of DYRK2/3 in comparison with
DYRK1A. These kinases require an arginine N-terminal to the
target residue for efficient substrate phosphorylation. This
cannot be replaced even by lysine. A peptide with arginine at
32 is phosphorylated much less well by all three kinases than
one with arginine at 33. Replacement of the +1 proline
by alanine almost completely eliminates substrate phosphoryla-
tion, but valine here does allow phosphorylation especially by
DYRK2. This study reveals both similarities and differences in
the specificities of these arginine-dependent protein kin-
ases. ß 2002 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Members of the dual speci¢city tyrosine phosphorylated
and regulated kinase (DYRK) group of kinases [1] have re-
cently been shown to phosphorylate translation initiation fac-
tor eIF2B and the microtubule-associated protein d in vitro
[2]. Of particular potential signi¢cance is the fact that they do
so at residues whose phosphorylation is known to be impor-
tant in priming the phosphorylation of adjacent serine resi-
dues (at 33) by glycogen synthase kinase-3 (GSK3) [2]. This
¢nding thus identi¢ed members of the DYRK family as can-
didates for the role of ‘priming kinase’ for the phosphoryla-
tion of these substrates by GSK3, an enzyme known to play
manifold roles in cellular physiology, including responses to
hormones, such as insulin, and growth factors.
In the case of eIF2B, the sites phosphorylated by DYRKs
and GSK3 lie in the catalytic domain of the largest (O) subunit
of this guanine nucleotide-exchange factor [2^4]. GSK3-medi-
ated phosphorylation inhibits the activity of mammalian or
insect eIF2B [3,5]. Since hormones such as insulin, which ac-
tivate eIF2B [6^8], inhibit GSK3 [9,10], this observation pro-
vides a potential signalling mechanism for the stimulation of
eIF2B by insulin, which is involved in switching on overall
protein synthesis.
The DYRKs comprise a poorly understood group of pro-
tein kinases [1]. The gene for DYRK1A lies within the so-
called Down syndrome critical region on chromosome 21
[11^15]. The Drosophila homologue Minibrain (MNB) ap-
pears to play an important role in the development of the
nervous system [16], suggesting that triplication of the DYR-
K1A may be involved in the mental retardation associated
with Down syndrome. Closely related enzymes in lower eu-
karyotes (Yak1 in budding yeast [17]; YakA in Dictyostelium
discoideum [18]) play key roles in nutrient signalling. The reg-
ulation of eIF2B activity is also modulated by nutrients
[19,20]. Mammalian DYRKs comprise a family of related
protein kinases, encoded by at least seven di¡erent genes in
mammals [21,22]. Our earlier studies showed that eIF2BO was
phosphorylated by DYRK1A and DYRK2 [2]. eIF2B is a
cytoplasmic protein while DYRK1A is nuclear [21], making
it unlikely that it is responsible for the phosphorylation of the
priming site in eIF2B in vivo. In contrast, DYRK2 is cyto-
plasmic [21]. Given that, like DYRK2 but unlike DYRK1A,
DYRK3 has no nuclear localisation signal [21], this isoform is
also likely to be cytoplasmic. It is thus clearly possible that
DYRK2 and DYRK3 also phosphorylate other cytoplasmic
proteins, and that this may important in nutrient signalling, to
prime GSK3-mediated phosphorylation of these proteins or
for other reasons. The substrate speci¢cities of the cytoplas-
mic DYRK isoforms (2 and 3) have not previously been ex-
amined. The present study therefore provides the ¢rst detailed
information on the basis of their substrate speci¢cities. It re-
veals important features of their sequence requirements for
e⁄cient phosphorylation of substrates, and subtle di¡erences
between their individual speci¢cities.
2. Materials and methods
2.1. Synthetic peptides
Synthetic peptides were prepared and puri¢ed by Dr Graham
Bloomberg (University of Bristol, Bristol, UK).
2.2. Protein kinases
Vectors encoding DYRK2 and DYRK3 as glutathione-S-transfer-
ase (GST)-fusion proteins were kindly provided by Dr Walter Becker
(Aachen, Germany). Proteins were expressed in Escherichia coli [21]
and puri¢ed over glutathione agarose. Bound proteins were eluted
from the resin with 20 mM glutathione. The puri¢ed enzymes were
dialysed against a bu¡er comprising 50 mM Tris^HCl (pH 7.5), 150
mM NaCl, 15 mM L-mercaptoethanol and 30% (v/v) glycerol to re-
0014-5793 / 02 / $22.00 ß 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 1 ) 0 3 2 2 1 - 5
*Corresponding author. Fax: (44)-1382-322424.
E-mail address: c.g.proud@dundee.ac.uk (C.G. Proud).
FEBS 25606 17-12-01
FEBS 25606 FEBS Letters 510 (2002) 31^36
move residual glutathione, and were stored at 380‡C. DYRK1A,
expressed as a GST-fusion protein in E. coli, was kindly provided
by Dr Chris Armstrong (Division of Signal Transduction Therapy,
University of Dundee, Dundee, UK).
2.3. Protein kinase assays
Protein kinase assays were performed in reaction mixtures (50 Wl) at
30‡C. Peptides were dissolved in 20 mM HEPES^KOH, pH 7.5, and
stored at 320‡C. Reactions contained substrate peptide at the stated
concentration, [Q-32P]ATP (30 cpm/nmol, ¢nal concentration 0.1 mM),
MgCl2 (1 mM) and DYRK2 or DYRK3, diluted in the above dialysis
bu¡er supplemented with 0.1 mg/ml bovine serum albumin as a car-
rier protein. At the appropriate times, samples were removed, spotted
onto 1.5U1.5 cm squares of phosphocellulose P81 peptide (Whatman)
which were then washed four times with 1% (v/v) orthophosphoric
acid. Radioactivity was determined by the Cí erenkov method. The
amount of kinase used was selected to give reaction kinetics within
the linear range based on pilot experiments performed with each batch
of kinase.
3. Results
To date, sites of phosphorylation have been identi¢ed for
members of the DYRK group in four proteins (Table 1). In
all cases, an arginyl residue is located two or three positions
N-terminal to the site phosphorylated by the DYRK. Studies
using a panel of peptide substrates suggested that an arginine
at 33 was very important for substrate phosphorylation by
DYRK1A [23], and replacement of the arginine by alanine in
‘Woodtide’ (a synthetic peptide based on the site in FKHR)
was reported to reduce drastically phosphorylation by DYR-
K1A or DYRK3. However, no systematic study of the spe-
ci¢city requirements of DYRK2, and no information at all for
DYRK3, has previously been presented.
To address this, we generated a panel of peptides based on
the sequence around Ser539 in eIF2BO which was designed to
explore the role of the arginyl residue N-terminal to the target
serine and the importance of the proline at +1 (Table 2). In
each of these peptides, the residue corresponding to Ser535
(the site for phosphorylation by GSK3) was changed to Ala,
to give peptides containing only one phosphorylatable residue,
and two arginine residues were added at the extreme N-termi-
nus to ensure the peptide would be bound to phosphocellulose
paper, for ease of assay (this is a widely used feature of syn-
thetic peptides used for protein kinase assays).
In peptide 1, the sequence around Ser539 of rat eIF2BO is
retained, apart from the modi¢cations noted above. In peptide
2, the proline in the +1 position relative to Ser539 is altered to
alanine. Peptides 3 and 4 contain arginines at the 32 and 31
positions rather than at 33 as in eIF2BO. In peptide 5, the
arginine residue at 33 is replaced by another basic residue,
lysine.
DYRK2 readily phosphorylated the parent peptide, peptide
1 (Fig. 1A,C), consistent with its ability to phosphorylate the
protein on whose sequence it is based, eIF2BO [2]. Each of the
above modi¢cations to the peptide sequence drastically re-
duced the ability of DYRK2 to phosphorylate the peptide.
The only variant that was signi¢cantly phosphorylated was
that containing an arginine at the 32 position (peptide 3,
Fig. 1A), but even this peptide was poorly phosphorylated
relative to the parent peptide. Peptide 2 was not phosphory-
lated signi¢cantly by DYRK2, showing the importance of a
proline at the +1 position (Fig. 1C), and consistent with the
presence of such a residue in this position adjacent to the two
known phosphorylation sites for DYRK2, in eIF2BO and Tau
[2] (Table 1). Shifting the arginine to position 31 (peptide 4)
also abolished phosphorylation. Even replacing the arginine at
33 by a similarly charged (basic) residue (lysine, peptide 5)
rendered the peptide an extremely poor substrate for
DYRK2. This is rather unusual in view of the speci¢cities
of a number of other protein kinases which use basic residues
as a recognition motif but can accept either lysine or arginine
[24].
In the case of DYRK3, the overall pattern was similar to
that observed for DYRK2 (Fig. 1B,D). DYRK3 readily phos-
phorylated the parent peptide (peptide 1), consistent with its
ability to phosphorylate eIF2BO (data not shown), the protein
from which this peptide is ‘derived’. Again, the only modi¢-
cation that is tolerated is ‘moving’ the arginine to the 32
Table 1
Sequences around residues known to be phosphorylated by members of the DYRK group of protein kinases
Protein Residue Local sequence DYRKs shown to act on it References
FKHR Ser329 ISGRLSPIM DYRK1A [31]
eIF2BO Ser539 DSRAGSPQL DYRK1A, 2 [2]
Tau Thr212 PGRSRTPLP DYRK1A [2]
Histone H3 Thr45 RYRPGTVAL DYRK1A [23]
(optimal peptide, DYRKtide) ^ FRPASPLR DYRK1A [23]
Sequences around residues known to be phosphorylated by members of the DYRK family are shown. The residue phosphorylated by the
DYRK enzyme is shown bold and the N-terminal arginyl residue is underlined.
Table 2
Peptides used in this study
Peptide number Sequence Comments
1 RREELDARAGSPQL Corresponds to sequence around Ser539 in eIF2BO, but Ser535 is changed to Ala
2 RREELDARAGSAQL As 1; Pro at +1 changed to Ala
3 RREELDAARGSPQL As 1; Arg now at 32
4 RREELDAAARSPQL As 1; Arg now at 31
5 RREELDAKAGSPQL As 1; Arg at 33 changed to Lys
6 RREELDARAGSVQL As 1; Pro at +1 replaced by Val
Woodtide [2] KKISGRLSPIMTEQ
Sequences are shown using the single letter code. The residue phosphorylated by DYRK family members is shown bold.
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position. The only obvious di¡erence between the patterns of
activity observed for DYRK2 and DYRK3 is that the activity
of DYRK3 against peptide 3 was not as severely reduced
compared to peptide 1, as is the case for DYRK2 (cf. Fig.
1A,B). Thus, when normalised for their activities against pep-
tide 1, DYRK3 showed substantially higher activity against
the peptide with arginine at 32 than DYRK2 did. This issue
is discussed further below.
From these data we can conclude that a proline at the +1
position is very important for the phosphorylation of sub-
strates by DYRK2 and that an arginine residue at the 31
position, or even conservative replacement of the arginine at
33 by lysine, almost completely abolishes phosphorylation by
DYRK2 or DYRK3.
In histone H3, which is a substrate for DYRK1A [23], the
+1 position is occupied by a valyl residue. We therefore syn-
thesised an additional peptide (‘6’ in Table 2) containing va-
line at this position. When tested at 50 WM, this peptide was
phosphorylated quite well by DYRK2 or DYRK3 (Fig.
1C,D).
To learn more about the e¡ects of modi¢cations on the
activity of DYRK2 and DYRK3 against di¡erent peptides,
we determined their kinetic parameters for the phosphoryla-
tion of the two best substrates, peptides 1 and 3, by perform-
ing assays at a range of peptide concentrations. Such an anal-
ysis was not possible for the other peptides (2, 4 and 5) as the
activities of DYRK2 and DYRK3 against them were so low.
Both kinases showed a relatively lower Km for the peptide
with arginine at 33 as compared to the corresponding peptide
where the arginine is at 32. For DYRK2, this change raised
the apparent Km more than 10-fold, from less that 50 WM to
more than 0.5 mM. For DYRK3, the e¡ect on the Km was
about four-fold, the Km with peptide 1 being about 0.1 mM
while for peptide 3 the value was 0.4 mM (Table 3). Each
kinase also displayed a decreased Vm with peptide 3 as com-
pared to peptide 1. Thus, for this series of peptides, an argi-
Fig. 1. Phosphorylation of peptides based on the sequence around Ser539 in eIF2BO by DYRK2 and DYRK3. Assays were performed as de-
scribed in Section 2 using DYRK2 (panels A,C) or DYRK 3 (panels B,D), samples being removed from the incubations at the times indicated.
All peptides were present at 50 WM. Panel A displays results obtained using peptides in which the basic residues N-terminal to the serine were
substituted or ‘moved’ relative to the serine: peptide 3 (E), peptide 4 (F), and peptide 5 (F) (lines for peptides 4 and 5 are coincident). Also
shown is the phosphorylation of Woodtide (a). Panel B shows data for peptides in which the residue in the +1 position relative to the serine
were substituted: peptide 2 (F) and peptide 6 (R). Peptide 1 (b) served as a control for experiments in both panels. For details of peptides see
Table 2. Similar ¢ndings were obtained in nine separate experiments (three for Woodtide) using three di¡erent batches of DYRK3 and two dif-
ferent batches of DYRK2. The activities of DYRK2 (panel C) and DYRK3 (panel D) were also measured using Woodtide as substrate.
Table 3
Kinetic parameters for phosphorylation of peptides with arginine at 32 or 33 by DYRK2 and DYRK3
Substrate Kinase
DYRK1A DYRK2 DYRK3
Km (WM) Relative Vmax Km (WM) Relative Vmax Km (WM) Relative Vmax
Peptide 1 (Arg at 33) s 1000 n.d. 45 þ 2.3 100 97 þ 3.6 100
Peptide 3 (Arg at 32) s 1000 n.d. 526 þ 15 51 þ 2.7 402 þ 18 66 þ 3.0
Peptide 6 (Val at +1) n.d. n.d. s 500 n.d. s 1000 n.d.
Kinetic parameters were determined by assaying the activity of DYRK2 and DYRK3 against the indicated peptide substrate across a range of
substrate concentrations. Data are based on at least three parallel determinations. Relative Vmax values are normalised to the activity observed
against peptide 1, arbitrarily set at 100. N.d. = not determined, due to low activity of the corresponding kinase for the peptide or problems
with the solubility of the peptide at the high concentrations required for the experiment.
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nine in position 33 gives a substrate for which DYRK2 and
DYRK3 display a lower Km and higher Vmax than when this
residue is located in position 32, thus explaining the di¡er-
ences in rates of phosphorylation seen in Fig. 1. Similar stud-
ies using peptide 6, with valine at +1, yielded non-linear data,
perhaps due to problems with the solubility of this more hy-
drophobic peptide at the relatively high concentrations re-
quired for attempts to study the Kms of DYRK2 and
DYRK3 for this peptide. We estimate that the Km values of
DYRK2 and DYRK3 for this peptide are in excess of 500 and
1000 WM, respectively, although we were unable to determine
these values with accuracy. Given these high Km values, the
fact that DYRK2 and DYRK3 phosphorylated these peptides
rapidly when tested at 50 WM suggests that the Vmax for
DYRK2 and DYRK3 against these peptides is also high.
The activity of DYRK3 seemed less sensitive to the position
of the arginine residue, especially when one considers the Km,
at least using peptides based on the sequence of eIF2BO. To
address this a little further, we assayed the relative activities of
DYRK2 and DYRK3 against another peptide in which the
arginine is at the 32 position, i.e. Woodtide, a peptide whose
sequence is based on that around the DYRK phosphorylation
site in FKHR (Tables 1 and 2). At the ¢xed concentration
chosen (50 WM), DYRK2 phosphorylated peptide 1 and
Woodtide at similar rates, while DYRK3 displayed substan-
tially higher activity against Woodtide (Fig. 1). Since the se-
quence of this peptide di¡ers in many respects from those of
the eIF2BO-based peptides used in this study, one cannot draw
any conclusions about speci¢city from this observation, other
than the point that again DYRK3 shows relatively higher
activity than DYRK2 against a peptide with the arginine in
the 32 rather than in the 33 position. To assess whether
phosphorylation by DYRK2 and DYRK3 occurred only at
the expected serine, the more C-terminal of the two in this
peptide, Woodtide, was labelled by either kinase, freed of
ATP and then subjected to mass spectrometric (M/S) analysis.
In each case, the singly phosphorylated derivative (m/z =
1667.9) but not the doubly phosphorylated species (m/z =
1747.8) was observed, showing that the peptide was only
phosphorylated at one site by DYRK2 or DYRK3. M/S
M/S analysis yielded a series of peptides in which C-terminal
residues had been removed. The series clearly demonstrated
that peptides from which the dehydroalanine generated by
L-elimination of phosphoserine had been lost all still con-
tained serine, indicating that only the more C-terminal serine
was actually phosphorylated by DYRK2 or DYRK3 (data
not shown).
Previous studies on the speci¢city of DYRK family kinases
have focused only on DYRK1A [23]. We therefore compared
the ability of DYRK2 and DYRK3 to phosphorylate the pep-
tides under study here with the activity of DYRK1A against
the same peptides. DYRK1A phosphorylated the eIF2BO-
based peptide (peptide 1) and peptide 3 (with Arg at 32)
with similar e⁄ciencies (Fig. 2A), but showed very little ac-
tivity against peptides 4 and 5. Thus, an arginine at 32 or 33
appears to be crucial for e⁄cient phosphorylation by DYR-
K1A. However, the activity against even peptides 1 and 3 was
very much (about 100-fold) less than that against Woodtide,
used as a control, when initial rates were compared. Other
features of Woodtide, which di¡er in several respects from
the eIF2BO-based peptides, render it a much better substrate
for DYRK1A: such a great di¡erence in activity was not
observed for DYRK2 and DYRK3 (Fig. 1). Consistent with
this, the Km values of DYRK1A for peptides 1 and 3 were too
high (s 1 mM) to determine with accuracy.
The activity of DYRK1A against peptide 2 (with Ala rather
than Pro at +1) was even lower than that seen against pep-
tides 4 and 5 (Fig. 2B). DYRK1A showed some activity
against peptide 6 (Val at +1), in contrast to DYRK2 and
DYRK3 which showed relatively better activity against this
peptide when compared to their activities against peptide 1
(Fig. 1C,D).
4. Discussion
The data presented here are the ¢rst characterisation of the
substrate speci¢cities of DYRK2 and DYRK3. Our ¢ndings
clearly show that these poorly understood enzymes show sim-
ilar substrate speci¢cities. This study reveals that, for e⁄cient
phosphorylation of the peptide substrates tested here, both
enzymes require an arginine at 32 or 33, the latter position
being preferred. The arginine cannot, perhaps surprisingly, be
replaced by lysine. A comprehensive study of the substrate
requirements of DYRK1A [23] revealed that this enzyme
also shows a very strong requirement for an N-terminal ar-
Fig. 2. Phosphorylation of peptides based on the sequence around
Ser539 in eIF2BO by DYRK1A. Assays were performed as described
in Section 2 using DYRK1A, samples being removed from the incu-
bations at the times indicated. All peptides were present at 50 WM.
Panel A displays results obtained using peptides in which the basic
residues N-terminal to the serine were substituted or ‘moved’ rela-
tive to the serine; symbols used are as for Fig. 1A,B. Panel B shows
data for peptides in which the residue at the +1 position relative to
the serine was substituted; symbols as Fig. 1C,D. Peptide 1 served
as a control for experiments in both panels. For details of peptides
see Table 2. The activities of DYRK1A was also measured using
Woodtide as substrate (a), but here DYRK1A was used at one
twentieth the amount used in the other reactions.
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ginyl residue, although in this case it appeared to be essential
that this residue lay in the 33, rather than the 32, position.
Using the present set of peptides, arginyl residues at 32 or 33
seemed to be roughly equally acceptable (Fig. 2A). For all
three kinases, a basic residue at 31 would not allow phos-
phorylation. For DYRK1A, the earlier study showed that a
proline at 32 was an important requirement, whereas this
does not seem to be the case for DYRK2 or DYRK3, since
neither the protein substrates so far identi¢ed for this enzyme
nor the peptide substrates used here have a proline in this
position. DYRK1A did phosphorylate Woodtide about two
orders of magnitude more rapidly than the eIF2BO-based pep-
tides, although the many di¡erences in sequence between these
substrates make it hard to discern the reason(s) for this strik-
ing di¡erence. In common with DYRK1A, this study shows
that replacement of the proline at +1 by alanine almost com-
pletely eliminates phosphorylation by DYRK2 and DYRK3
(and also, in keeping with the earlier report, DYRK1A). In-
terestingly, replacement of the +1 proline by a hydrophobic
residue, valine, yielded a peptide that was a good substrate for
DYRK2, and (poorer) substrate for DYRK3 or DYRK1A.
This suggests that DYRK2 in particular may be able to phos-
phorylate Ser^Val (or perhaps, although this was not tested
here, Ser^Leu/Ile) sites in proteins; however, the Km of
DYRK2 for the valine-containing substrate was very high
(mM), so these such sites may not be physiological substrates.
The work of Himpel et al. [23] previously showed that the
requirement for an N-terminal arginine residue distinguished
DYRK1A from ERK2, a member of another major group of
protein-directed kinases. These authors suggested that, based
on the three-dimensional structures of other kinases that
phosphorylate target sites with adjacent N-terminal basic res-
idues, such as cAMP-dependent protein kinase, Asp-247
might interact with the arginine at 33 in the substrate [23].
In view of our ¢nding that DYRK2 and DYRK3 also show a
requirement for an arginine in this position, it is therefore
interesting to note that the position corresponding to
Asp247 is also occupied by an acidic residue in DYRK2
(Glu229) and DYRK3 (Glu254). Other DYRK-related ki-
nases such as DYRK1A [22] and DYRK4 [21], the Dictyo-
stelium homologue YakA [18] and the Drosophila MNB pro-
tein [16] also possess a Glu at this position, raising the
possibility that the requirement for an arginine N-terminal
to the target residue in their substrates is a common feature
of the speci¢city of members of the DYRK family of protein
kinases. However, their substrate speci¢cities are clearly not
identical as exempli¢ed by the observation [21] that DYRK2
and DYRK3 can phosphorylate histone H2B while DYRK1A
cannot.
The peptides used here form the basis of simple assays for
the activities of DYRK2 and DYRK3. The sequences of these
peptides are based on the sequence around the GSK3 site in
eIF2BO. Sequences are now known for this protein from a
number of species. The eIF2BO proteins from mammals and
from the fruit£y Drosophila melanogaster are phosphorylated
by GSK3 [3,5,25] and contain a serine (or threonine, Droso-
phila) at the ‘priming position’ (+4 relative to the GSK3 site).
In every case, this is followed by a proline and preceded at 33
by an arginine [3,5] (porcine sequence SRTGSP, accession
number AW416134.1). This is consistent with the idea that
members of the DYRK family such as the cytoplasmic forms
DYRK2 and DYRK3 are responsible for phosphorylating the
priming site in mammals, although further work will be re-
quired to prove this. On the other hand, the sequence adjacent
to the GSK3 sites in glycogen synthase, another cytoplasmic
GSK3 substrate that requires priming, does not contain a
DYRK consensus sequence, suggesting that DYRKs may
not be the priming kinase in this case. Skurat and Roach
[26,27] have provided data that sites 3a/b in glycogen synthase
may be phosphorylated independently of one another, while
phosphorylation of the other two GSK3 sites in glycogen
synthase, 3c/d, is thought to be primed by phosphorylation
of site 5 by casein kinase 2 [28,29]. Similarly, the sequence
around the probable priming phosphorylation site in ATP-
citrate lyase [30] fails to conform to the DYRK2/3 consensus.
It is therefore possible that other protein kinases, perhaps so
far uncharacterised members of the DYRK family with di¡er-
ent substrate speci¢cities, phosphorylate the priming sites in
these GSK3 substrates.
This characterisation of the substrate speci¢cities of DYRK
family kinases may assist the identi¢cation of further potential
substrates for this little-studied group of enzymes.
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